(Name of Issuer)
(Title of Class of Securities)
(CUSIP Number)
(Date of Event which Requires Filing of this Statement)
1
|
NAMES OF REPORTING PERSONS
Dennis Higgs
|
||
2
|
CHECK THE APPROPRIATE BOX IF A
MEMBER OF A GROUP
(a) ☐ (b) ☐ |
||
3
|
SEC USE ONLY
|
||
4
|
SOURCE OF FUNDS (SEE INSTRUCTIONS)
PF
|
||
5
|
CHECK BOX IF DISCLOSURE OF LEGAL
PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2 ☐
Not Applicable
|
||
6
|
CITIZENSHIP OR PLACE OF ORGANIZATION
Canada
|
||
NUMBER OF
SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH: |
7
|
SOLE VOTING POWER
As of May 3, 2022: 1,700,000(1)
As of September 27, 2022: 2,233,334(2) As of August 18, 2023: 2,379,001(3) As of October 2, 2023: 2,639,001(4) As of November 9, 2023: 3,669,001(5) |
|
8
|
SHARED VOTING POWER
0
|
||
9
|
SOLE DISPOSITIVE POWER
As of May 3, 2022: 1,700,000(1)
As of September 27, 2022: 2,233,334(2) As of August 18, 2023: 2,379,001(3) As of October 2, 2023: 2,639,001(4) As of November 9, 2023: 3,669,001(5) |
||
10
|
SHARED DISPOSITIVE POWER
0
|
||
11
|
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
As of May 3, 2022: 1,700,000(1)
As of September 27, 2022: 2,233,334(2) As of August 18, 2023: 2,379,001(3) As of October 2, 2023: 2,639,001(4) As of November 9, 2023: 3,669,001(5) |
||
12
|
CHECK BOX IF THE AGGREGATE AMOUNT
IN ROW (11) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS) ☐
NOT APPLICABLE
|
||
13
|
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
As of May 3, 2022: 12.78% (6)
As of September 27, 2022: 16.79% (6) As of August 18, 2023: 17.82%(7) As of October 2, 2023: 19.41% (8) As of November 9, 2023: 26.03% (9) |
||
14
|
TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
IN
|
||
|
|
|
|
(1)
|
Includes 1,666,667 Common Shares and options to purchase 33,333 Common Shares.
|
(2)
|
Includes 2,200,001 Common Shares and options to purchase 33,333 Common Shares.
|
(3)
|
Includes 2,304,001 Common Shares and options to purchase 75,000 Common Shares.
|
(4)
|
Includes 2,314,001 Common Shares and options to purchase 325,000 Common Shares.
|
(5)
|
Includes 2,794,001 Common Shares, 50,000 Common Shares owned by Reporting Person’s family member who resides with him, and
options to purchase 825,000 Common Shares.
|
(6)
|
The percentages used herein are calculated based upon 13,271,750 outstanding Common Shares of the Issuer, plus 33,333 Common
Shares in aggregate underlying convertible securities which are beneficially owned by the Reporting Person and included pursuant to Rule 13d-3(d)(1)(i) of the Act.
|
(7)
|
The percentages used herein are calculated based on 13,271,750 outstanding Common Shares of the issuer, plus 75,000 Common
Shares in aggregate underlying convertible securities which are beneficially owned by the Reporting Person and included pursuant to Rule 13d-3(d)(1)(i) of the Act.
|
(8)
|
The percentages used here are calculated based on 13,271,750 outstanding Common Shares of the Issuer, plus 325,000 Common Shares
in aggregate underlying convertible securities which are beneficially owned by the Reporting Person and included pursuant to Rule 13d-3(d)(1)(i) of the Act.
|
(9)
|
The percentages used here are calculated based on 13,271,750 outstanding Common Shares of the Issuer, plus 825,000 Common Shares
in aggregate underlying convertible securities which are beneficially owned by the Reporting Person and included pursuant to Rule 13d-3(d)(1)(i) of the Act.
|
Item 1. |
Security and Issuer
|
(a) |
Title of Class of Securities:
|
(b) |
Name of Issuer:
|
(c) |
Address of Issuer's Principal Executive Offices:
|
Item 2. |
Identity and Background
|
(a) |
Name of Reporting Person:
|
(b) |
Address of Principal Business Office:
|
(c) |
Occupation, Employment and Other Information:
|
(d) |
Criminal convictions:
|
(e) |
Civil proceedings:
|
(f) |
Citizenship:
|
Item 3. |
Source and Amount of Funds or Other Consideration:
|
(a)
|
April 2020 – Common Share Purchase
|
(b)
|
December 2020 – Option
Grant
|
(c)
|
September 2022 – Common
Share Purchase
|
(d)
|
October 2022 – Option
Grant
|
(e)
|
October 2022 – June 2023 – UBEX Common Share Purchases
|
Date
|
Number of Shares
|
Purchase Price
|
10/31/2022
|
2,500
|
$0.80
|
11/1/2022
|
1,500
|
$0.77
|
12/23/2022
|
1,200
|
$0.75
|
12/27/2022
|
100
|
$0.75
|
1/20/2023
|
4,700
|
$1.02
|
2/10/2023
|
2,276
|
$1.00
|
5/18/2023
|
20,000
|
$1.0353
|
5/26/2023
|
5,000
|
$1.00
|
5/26/2023
|
1,919
|
$0.99
|
5/30/2023
|
10,805
|
$0.9909
|
6/16/2023
|
2,500
|
$0.99
|
6/30/2023
|
5,000
|
$0.85
|
(f)
|
June 2023 – October 2023 – Common Share Purchases
|
Date
|
Number of Shares
|
Purchase Price
|
6/16/2023
|
10,000
|
$0.95
|
6/22/2023
|
5,000
|
$0.93
|
6/22/2023
|
2,500
|
$0.89
|
6/23/2023
|
2,500
|
$0.87
|
7/31/2023
|
3,094
|
$0.85
|
8/7/2023
|
4,906
|
$0.85
|
8/8/2023
|
2,500
|
$0.83
|
8/11/2023
|
1,900
|
$0.80
|
8/14/2023
|
3,100
|
$0.80
|
8/17/2023
|
1,671
|
$0.77
|
8/18/2023
|
5,000
|
$0.7199
|
8/18/2023
|
3,500
|
$0.7495
|
8/18/2023
|
829
|
$0.77
|
9/26/2023
|
3,472
|
$0.74
|
9/28/2023
|
1,301
|
$0.74
|
10/2/2023
|
340
|
$0.7466
|
10/2/2023
|
4,887
|
$0.75
|
(g)
|
October 2023 – Option Grant
|
(h)
|
November 2023 – Option Grant
|
(i)
|
November 2023 – Common
Share Purchases
|
Item 4. |
Purpose of Transaction
|
(a)
|
April 2020 – Common Share Purchase
|
(b)
|
September 2022 Common Share Purchase
|
(c)
|
October 2022 – June 2023 – UBEX Common Share Purchases
|
(d)
|
June 2023 – October 2023 – Common Share Purchases
|
(e)
|
December 2020, October 2022, October 2023, and November 2023 Option Grants
|
(f)
|
November 2023 – Common Share Purchase
|
Item 5. |
Interest in Securities of the Issuer:
|
(a) |
As of November 9, 2023, the Reporting Person may be deemed to beneficially own 3,669,001 Common Shares, representing approximately 26.03% of the Issuer’s Common Shares
(on the basis of 13,271,750 outstanding common shares of the Issuer, plus 825,000 common shares in aggregate underlying convertible securities which are beneficially owned by the Reporting Person and included pursuant to Rule 13d-3(d)(1)(i) of
the Act). The total number of Common Shares reported includes (i) 2,736,501 Common Shares held directly by the Reporting Person, (ii) 57,500 Common Shares held indirectly by the Reporting Person through UBEX, (iii) 50,000 Common Shares held by
a family member who resides with the Reporting person, and (iv) 825,000 in stock options exercisable for Common Shares, held directly by the Reporting Person.
|
(b) | (i) | Sole power to vote or to direct the vote: 3,669,001 Common Shares |
(ii) |
Shared power to vote or to direct the vote: 0 Common Shares
|
(iii) |
Sole power to dispose or direct the disposition: 3,669,001 Common Shares
|
(iv) |
Shared power to dispose or direct the disposition: 0 Common Shares.
|
(c) |
Not applicable.
|
(d) |
Not applicable.
|
(e) |
Not applicable.
|
Item 6. |
Contracts, Arrangements, Understandings or Relationships with Respect to Securities of the Issuer:
|
Item 7. |
Material to Be Filed as Exhibits:
|
Exhibit 10.1 |
Stock Option Plan dated December 1, 2020 (incorporated by reference to Exhibit
10.1 to the Form S-1 registration statement as filed with the Commission on June11, 2021, File No. 333-260404)
|
Exhibit 10.2 |
Amended and Restated Stock Option Plan, effective July 5, 2021 (incorporated by reference to Exhibit 10.1 to the Form S-1 registration statement as filed with the Commission on October 21, 2021, File No. 333-260404)
|
Exhibit 10.3 |
2023 Stock Incentive Plan, effective May 10, 2023 (incorporated by reference to Exhibit 4.3 to the Form S-8 registration statement filed with the Commission on June 30, 2023, File No. 333-273046)
|
Exhibit 10.4 |
Stock Purchase Agreement dated September 26, 2022 by and between the Reporting Person and Kenneth McNaughton and Joseph Ovsenek
|
Exhibit 10.5 |
Stock Purchase Agreement dated October 18, 2023 by and between the Reporting Person and Joseph Ovsenek
|
Exhibit 10.6 |
Stock Purchase Agreement dated October 18, 2023 by and between the Reporting Person and Kenneth McNaughton.
|
Exhibit 10.7 |
Stock Purchase Agreement dated October 18, 2023 by and between Brooklyn Higgs and Joseph Ovsenek
|